Graft-versus-host disease can be separated from graft-versus-lymphoma effects by control of lymphocyte trafficking with FTY720
J. Clin. Invest. Yong-Mi Kim, et al. 111:659
doi:10.1172/JCI16950 [Go to this article.]

Problems with a PDF?